ArticleVaccine2009

A genetically engineered adenovirus vector targeted to CD40 mediates transduction of canine dendritic cells and promotes antigen-specific immune responses in vivo.

Erin E Thacker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.